Earnings call briefThird-quarter 2026

Danaher DHR

Danaher says it is planning $1.5 billion of respiratory revenue this year

The company said 4% to 5% core revenue growth, excluding respiratory revenue, is the right starting point for 2027, with a more quantitative outlook to follow in January.

GetSignal 

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

President and Chief Executive Officer Julie Sawyer Montgomery said on the third-quarter call that the company is planning for $1.5 billion of respiratory revenue this year to reflect a middle-of-the-road flu season.

She said the same $1.5 billion is also the right starting point for next year.

Quotes from the call

“As we look to 2027, we think that 4%-5% core revenue growth, excluding respiratory revenue, is the right starting point as we sit today.”

Matt Gugino, Executive Vice President and Chief Financial Officer

Key facts from the call

Planned 2026 respiratory revenue
$1.5 billion
Expected 2027 core revenue growth starting point
4% to 5%, excluding respiratory revenue
Expected timing of quantitative 2027 outlook
January

All DHR call briefs

Source: Danaher's third-quarter 2026 earnings call, October 21, 2026.

Written by GetSignal with AI from the company's earnings call. How we make news

Not investment advice.

More earnings call briefs

The newest

All earnings call briefs